Evofem Biosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch EVFM and buy or sell other stocks, options, and ETFs commission-free!

About EVFM

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. 

CEO
Saundra L. Pelletier
CEOSaundra L. Pelletier
Employees
119
Employees119
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
119
Employees119

EVFM Key Statistics

Market cap
30.11M
Market cap30.11M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
5.57M
Average volume5.57M
High today
$0.18
High today$0.18
Low today
$0.169
Low today$0.169
Open price
$0.175
Open price$0.175
Volume
1.33M
Volume1.33M
52 Week high
$1.42
52 Week high$1.42
52 Week low
$0.1104
52 Week low$0.1104
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.